1
|
Congdon NG, Friedman DS and Lietman T:
Important causes of visual impairment in the world today. JAMA.
290:2057–2060. 2003. View Article : Google Scholar : PubMed/NCBI
|
2
|
Armulik A, Abramsson A and Betsholtz C:
Endothelial/pericyte interactions. Circ Res. 97:512–523. 2005.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Caldwell RB, Bartoli M, Behzadian MA,
El-Remessy AE, Al-Shabrawey M, Platt DH and Caldwell RW: Vascular
endothelial growth factor and diabetic retinopathy:
Pathophysiological mechanisms and treatment perspectives. Diabetes
Metab Res Rev. 19:442–455. 2003. View
Article : Google Scholar : PubMed/NCBI
|
4
|
Saltiel AR and Pessin JE: Insulin
signaling pathways in time and space. Trends Cell Biol. 12:65–71.
2002. View Article : Google Scholar : PubMed/NCBI
|
5
|
Ferrara N: Role of vascular endothelial
growth factor in regulation of physiological angiogenesis. Am J
Physiol Cell Physiol. 280:C1358–C1366. 2001.PubMed/NCBI
|
6
|
Behl T and Kotwani A: Exploring the
various aspects of the pathological role of vascular endothelial
growth factor (VEGF) in diabetic retinopathy. Pharmacol Res.
99:137–148. 2015. View Article : Google Scholar : PubMed/NCBI
|
7
|
Poulaki V, Qin W, Joussen AM, Hurlbut P,
Wiegand SJ, Rudge J, Yancopoulos GD and Adamis AP: Acute intensive
insulin therapy exacerbates diabetic blood-retinal barrier
breakdown via hypoxia-inducible factor-1alpha and VEGF. J Clin
Invest. 109:805–815. 2002. View Article : Google Scholar : PubMed/NCBI
|
8
|
Jiang ZY, He Z, King BL, Kuroki T, Opland
DM, Suzuma K, Suzuma I, Ueki K, Kulkarni RN, Kahn CR and King GL:
Characterization of multiple signaling pathways of insulin in the
regulation of vascular endothelial growth factor expression in
vascular cells and angiogenesis. J Biol Chem. 278:31964–31971.
2003. View Article : Google Scholar : PubMed/NCBI
|
9
|
American Diabetes Association, .
Peripheral arterial disease in people with diabetes. Diabetes Care.
26:3333–3341. 2003. View Article : Google Scholar : PubMed/NCBI
|
10
|
Waltenberger J: Impaired collateral vessel
development in diabetes: Potential cellular mechanisms and
therapeutic implications. Cardiovasc Res. 49:554–560. 2001.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Carlsson PO and Jansson L: Disruption of
insulin receptor signaling in endothelial cells shows the central
role of an intact islet blood flow for in vivo β-cell function.
Diabetes. 64:700–702. 2015. View Article : Google Scholar : PubMed/NCBI
|
12
|
Tardif K, Hertig V, Dumais C, Villeneuve
L, Perrault L, Tanguay JF and Calderone A: Nestin downregulation in
rat vascular smooth muscle cells represents an early marker of
vascular disease in experimental type I diabetes. Cardiovasc
Diabetol. 13:1192014. View Article : Google Scholar : PubMed/NCBI
|
13
|
Park SW, Yun JH and Kim JH, Kim KW, Cho CH
and Kim JH: Angiopoietin 2 induces pericyte apoptosis via α3β1
integrin signaling in diabetic retinopathy. Diabetes. 63:3057–3068.
2014. View Article : Google Scholar : PubMed/NCBI
|
14
|
Jiang ZY, Lin YW, Clemont A, Feener EP,
Hein KD, Igarashi M, Yamauchi T, White MF and King GL:
Characterization of selective resistance to insulin signaling in
the vasculature of obese Zucker (fa/fa) rats. J Clin Invest.
104:447–457. 1999. View
Article : Google Scholar : PubMed/NCBI
|
15
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Zhang J, Du YY, Lin YF, Chen YT, Yang L,
Wang HJ and Ma D: The cell growth suppressor, mir-126, targets
IRS-1. Biochem Biophys Res Commun. 377:136–140. 2008. View Article : Google Scholar : PubMed/NCBI
|
17
|
Figliolini F, Cantaluppi V, De Lena M,
Beltramo S, Romagnoli R, Salizzoni M, Melzi R, Nano R, Piemonti L,
Tetta C, et al: Isolation, characterization and potential role in
beta cell-endothelium cross-talk of extracellular vesicles released
from human pancreatic islets. PLoS One. 9:e1025212014. View Article : Google Scholar : PubMed/NCBI
|
18
|
Bandello F, Lattanzio R, Zucchiatti I and
Del Turco C: Pathophysiology and treatment of diabetic retinopathy.
Acta Diabetol. 50:1–20. 2013. View Article : Google Scholar : PubMed/NCBI
|
19
|
Liang D, Zhong P, Hu J, Lin F, Qian Y, Xu
Z, Wang J, Zeng C, Li X and Liang G: EGFR inhibition protects
cardiac damage and remodeling through attenuating oxidative
stressin STZ-induced diabetic mouse model. J Mol Cell Cardiol.
82:63–74. 2015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Su X, Sorenson CM and Sheibani N:
Isolation and characterization of murine retinal endothelial cells.
Mol Vis. 9:171–178. 2003.PubMed/NCBI
|
21
|
Buzney SM, Massicotte SJ, Hetu N and
Zetter BR: Retinal vascular endothelial cells and pericytes.
Differential growth characteristics in vitro. Invest Ophthalmol Vis
Sci. 24:470–480. 1983.PubMed/NCBI
|
22
|
Meng S, Cao JT, Zhang B, Zhou Q, Shen CX
and Wang CQ: Downregulation of microRNA-126 in endothelial
progenitor cells from diabetes patients, impairs their functional
properties, via target gene Spred-1. J Mol Cell Cardiol. 53:64–72.
2012. View Article : Google Scholar : PubMed/NCBI
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Zhang J, Du YY, Lin YF, Chen YT, Yang L,
Wang HJ and Ma D: The cell growth suppressor, mir-126, targets
IRS-1. Biochem Biophys Res Commun. 377:136–140. 2008. View Article : Google Scholar : PubMed/NCBI
|
25
|
Cesarone G, Garofalo C, Abrams MT,
Igoucheva O, Alexeev V, Yoon K, Surmacz E and Wickstrom E:
RNAi-mediated silencing of insulin receptor substrate 1 (IRS-1)
enhances tamoxifen-induced cell death in MCF-7 breast cancer cells.
J Cell Biochem. 98:440–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
26
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of humangenes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
27
|
Hoeppner LH, Sinha S, Wang Y, Bhattacharya
R, Dutta S, Gong X, Bedell VM, Suresh S, Chun C, Ramchandran R, et
al: RhoC maintains vascular homeostasis by regulating VEGF-induced
signaling in endothelial cells. J Cell Sci. 128:3556–3568. 2015.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Simó R, Sundstrom JM and Antonetti DA:
Ocular anti-VEGF therapy for diabetic retinopathy: The role of VEGF
in the pathogenesis of diabetic retinopathy. Diabetes Care.
37:893–899. 2014. View Article : Google Scholar : PubMed/NCBI
|
29
|
King GL, Goodman AD, Buzney S, Moses A and
Kahn CR: Receptors and growth-promoting effects of insulin and
insulinlike growth factors on cells from bovine retinal capillaries
and aorta. J Clin Invest. 75:1028–1036. 1985. View Article : Google Scholar : PubMed/NCBI
|
30
|
Kerouz NJ, Hörsch D, Pons S and Kahn CR:
Differential regulation of insulin receptor substrates-1 and-2
(IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in
liver and muscle of the obese diabetic (ob/ob) mouse. J Clin
Invest. 100:3164–3172. 1997. View Article : Google Scholar : PubMed/NCBI
|
31
|
Ryu HS, Park SY, Ma D, Zhang J and Lee W:
The induction of microRNA targeting IRS-1 is involved in the
development of insulin resistance under conditions of mitochondrial
dysfunction in hepatocytes. PLoS One. 6:e173432011. View Article : Google Scholar : PubMed/NCBI
|
32
|
Wang S, Aurora AB, Johnson BA, Qi X,
McAnally J, Hill JA, Richardson JA, Bassel-Duby R and Olson EN: The
endothelial-specific microRNA miR-126 governs vascular integrity
and angiogenesis. Dev Cell. 15:261–271. 2008. View Article : Google Scholar : PubMed/NCBI
|
33
|
Shibuya M and Claesson-Welsh L: Signal
transduction by VEGF receptors in regulation of angiogenesis and
lymphangiogenesis. Exp Cell Res. 312:549–560. 2006. View Article : Google Scholar : PubMed/NCBI
|
34
|
Kanehisa M, Furumichi M, Tanabe M, Sato Y
and Morishima K: KEGG: New perspectives on genomes, pathways,
diseases and drugs. Nucleic Acids Res. 45:D353–D361. 2017.
View Article : Google Scholar : PubMed/NCBI
|